{"chunk_id": "WHO_GUIDELINES(TRAIN DATA)__chunk_652", "source": "WHO_GUIDELINES(TRAIN DATA)", "text": "inty evidence suggests that a single dose of \nalbendazole or mebendazole in the second trimester \nof pregnancy may have little or no effect on maternal \nanaemia (defined as Hb < 11 g/ dL) (4 trials, 3266 \nwomen; RR: 0.94; 95% CI: 0.81–1.10).\nFetal and neonatal outcomes\nModerate-certainty evidence indicates that a single \ndose of albendazole or mebendazole in the second \nChapter 3. Evidence and recommendations \n69\ntrimester of pregnancy probably has little or no effect \non preterm birth (2 trials"}